ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1213

Prediction Model for the Two-Year Risk of Fracture Among Older US Women

Annette Adams1, Akhila Balasubramanian2, Hui Zhou3, Robert Platt4, Deborah Wenkert5, Steven Jacobsen3 and Eric Johnson6, 1Kaiser Permanente Southern California, Pasadean, CA, 2Amgen Inc., Thousand Oaks, CA, 3Kaiser Permanente Southern California, Pasadena, CA, 4McGill University, Montreal, QC, Canada, 5Wenkert & Young, LLC, Thousand Oaks, CA, 6Kaiser Permanente Northwest, Portland, OR

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: fracture risk and osteoporosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: Osteoporosis and Metabolic Bone Disease – Clinical Aspects and Pathogenesis Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Current algorithms for identifying patients at high risk of fracture focus on long-term risk. We developed simple 10- and 3-predictor models and points-based risk scores to enable pragmatic identification of patients at near-term (12-24 months) risk of fracture.  Physicians and patients could benefit from such models to ensure timely care.

Methods: This retrospective cohort study included women ≥50 years who had dual-energy x-ray absorptiometry (DXA) bone mineral density (BMD) data and were members of an integrated healthcare delivery system in the United States. Clinic location determined inclusion in the development vs. validation cohort. Using randomly selected outpatient visits (2008- 2012) as index dates, we followed women up to 2 years for the occurrence of “any fracture” – closed fracture other than skull/face/fingers/toes. We adapted our previously validated 10- and 3-predictor models to predict 2-year fracture risks among the subgroup of women with recent BMD T-scores, using Cox regression. We used predictor coefficients from these models to develop risk score points.

Results: 68,589 women in the development cohort (mean±sd age 67.0±9.6 years, 1,816 fractures) and 58,812 women in the validation cohort (age 67.2±9.8 years, 1,440 fractures) had an overall 2-year fracture rate of 2.6% and 2.4%, respectively. We developed a 10-predictor model for “any fracture,” which included age, race/ethnicity, body mass index (BMI), BMD T-score, fracture in the prior year, fall risk, tobacco use, and use of antidepressant, narcotic, and glucocorticoid medications. This model discriminated risk effectively in both the development cohort (c-statistic = 0.75) and the external validation cohort (c-statistic = 0.76). Our reduced, 3-predictor model included age, recent fracture, and BMD T-score, and explained 88.4% of the variation in the 10-variable model. Discrimination was 0.72 in the development and 0.73 in the external validation cohorts. Calibration plots revealed excellent agreement between observed and predicted risks. A 2-year predicted risk ≥10% in the 3-predictor model accounted for 4% of patients and 20% of fractures in the total study population (Table 1). We also developed a points-based risk score for easy implementation of the model to identify patients at high near-term fracture risk (Table 2).

Conclusion: Our data suggest that models using as few as 3 variables can perform well in estimating near-term fracture risk. Our simple models can aid in identification of patients in greatest need of impactful interventions to quickly lower fracture risk.

 

Table 1. Agreement between observed (Kaplan-Meier) and predicted two-year fracture risks in external validation cohort, with the range of risk score points for the three-predictor model of all fractures.

Predicted risk

Number of Patients

Number of any fracture  (crude risk, %)

KM observed risk (%)

Mean ± SD predicted risk (%)

Median predicted risk (%) (q1-q3)

Range of risk score points

 

0 to 1.49%

12,830

86 (0.67)

0.66

0.9 ± 0.3

0.8 (0.7-1.2)

0 to 44

 

1.50 to 4.99%

37,280

716 (1.92)

1.79

2.4 ± 0.9

2.3 (1.6-2.9)

47 to 91

 

5.00 to 9.99%

6,403

359 (5.61)

5.51

6.8 ± 1.4

6.5 (5.8-7.8)

92 to 120

 

10.00 to 14.99%

1,480

151 (10.20)

10.27

11.9 ± 1.4

11.6 (10.6-12.9)

121 to 137

 

≥15.00%

819

128 (15.63)

17.12

22.3 ± 7.9

19.5 (16.7-25.0)

≥138

 

 

Table 2. Contribution of individual predictors to points-based risk score from the three-predictor model

Age

Points

BMD T-score

Points

History of fracture

Points

50 to 54

0

>= -1.0

0

No

0

55 to 59

12

 -2.5 to < -1.0

29

Yes

40

60 to 64

19

-3.5 to < -2.5

45

 

 

65 to 69

15

-4.5 to < -3.5

60

 

 

70 to 74

25

< -4.5

71

 

 

75 to 79

42

 

 

 

 

80 to 84

55

 

 

 

 

 


Disclosure: A. Adams, Amgen Inc, 2,Merck Pharmaceuticals, 2,Otsuka, 2; A. Balasubramanian, Amgen, 3,Amgen, 1; H. Zhou, None; R. Platt, Pfizer Inc, 5,Eli Lilly and Company, 5,Amgen, 5,Searchlight Pharma, 5; D. Wenkert, Amgen, 1,Amgen, 5,Alexion Pharmaceuticals, Inc., 5,Amgen, 3; S. Jacobsen, None; E. Johnson, Amgen, 2.

To cite this abstract in AMA style:

Adams A, Balasubramanian A, Zhou H, Platt R, Wenkert D, Jacobsen S, Johnson E. Prediction Model for the Two-Year Risk of Fracture Among Older US Women [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/prediction-model-for-the-two-year-risk-of-fracture-among-older-us-women/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prediction-model-for-the-two-year-risk-of-fracture-among-older-us-women/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology